CD4:CD8 ratio works as a frontier marker for clinical outcome,immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients and is no more considered as of no use as stated in past history - Welcome To IndiaHeartBeat.Com India's Leading Online Doctor Directory, Live Help

World's first medical networking and resource portal

Community Weblogs

Jul01

CD4:CD8 ratio works as a frontier marker for clinical outcome,immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients and is no more considered as of no use as stated in past history

PROF.DRRAM ,HIV/AIDS,SEX Diseases, Hepatitis .& Deaddiction Expert
profdrram@gmail.com,+917838059592,+919832025033,DELHI,INDIA
HIV/ AIDS,CANCER MODERN MEDICINES AVAILABLE AT CHEAP RATE.
FOLLOW ON FACE BOOK:www.facebook.com/ramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram

Absolute CD4 T cell count and plasma viral load have been established as predictors of HIV disease progression, and CD4 T cell count is used as an indicator for initiation of antiretroviral therapy. Following long-term therapy, patients generally present with significant CD4 T cell recovery contrasting with persistently elevated CD8 T cell counts, which leads to a partial restoration of CD4:CD8 ratio. This review focuses on the relevance of the CD4:CD8 ratio on clinical outcomes, immune dysfunction and HIV reservoir size in long-term treated patients.

Low CD4:CD8 ratio has been linked to ageing and acts as a predictor of mortality in the general population. This ratio may represent the combined effects of inflammation and immunological changes called “inflammaging.” Although the mechanisms underlying partial correction of the CD4:CD8 ratio and persistently elevated CD8 T cell count in long-term treated patients remain poorly understood, it has been recently indicated that patients with optimal CD4 T cell recovery and low CD4:CD8 ratio still harbour increased immune activation, an immune senescent phenotype and have a higher risk of non-AIDS morbidity and mortality. This review reconsiders CD4:CD8 ratio in the light of advances in the understanding of immune dysfunction and examines its pathophysiological features and implications on clinical outcome and HIV reservoir size in long-term treated HIV-positive adults.

Posted on Wednesday, 1st July 2015

Comments (0) | CD4:CD8 ratio works as a frontier marker for clinical outcome,immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients and is no more considered as of no use as stated in past history